136 related articles for article (PubMed ID: 38889384)
1. Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis.
Ciccarelli O; Barkhof F; Calabrese M; De Stefano N; Eshaghi A; Filippi M; Gasperini C; Granziera C; Kappos L; Rocca MA; Rovira À; Sastre-Garriga J; Sormani MP; Tur C; Toosy AT;
Neurology; 2024 Jul; 103(1):e209444. PubMed ID: 38889384
[TBL] [Abstract][Full Text] [Related]
2. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A; Schaedelin S; Barakovic M; Benkert P; Todea RA; Rahmanzadeh R; Galbusera R; Lu PJ; Weigel M; Melie-Garcia L; Ruberte E; Siebenborn N; Battaglini M; Radue EW; Yaldizli Ö; Oechtering J; Sinnecker T; Lorscheider J; Fischer-Barnicol B; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Chan A; Salmen A; Pot C; Bridel C; Zecca C; Derfuss T; Lieb JM; Remonda L; Wagner F; Vargas MI; Du Pasquier R; Lalive PH; Pravatà E; Weber J; Cattin PC; Gobbi C; Leppert D; Kappos L; Kuhle J; Granziera C
JAMA Neurol; 2022 Jul; 79(7):682-692. PubMed ID: 35575778
[TBL] [Abstract][Full Text] [Related]
3. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
[TBL] [Abstract][Full Text] [Related]
4. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A; Benkert P; Melie-Garcia L; Schaedelin SA; Leber S; Tsagkas C; Barakovic M; Galbusera R; Lu PJ; Weigel M; Ruberte E; Radue EW; Yaldizli Ö; Oechtering J; Lorscheider J; D'Souza M; Fischer-Barnicol B; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Chan A; Salmen A; Pot C; Bridel C; Zecca C; Derfuss T; Lieb JM; Remonda L; Wagner F; Vargas MI; Du Pasquier RA; Lalive PH; Pravatà E; Weber J; Cattin PC; Absinta M; Gobbi C; Leppert D; Kappos L; Kuhle J; Granziera C
Neurology; 2024 Jan; 102(1):e207768. PubMed ID: 38165377
[TBL] [Abstract][Full Text] [Related]
5. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
Absinta M; Sati P; Masuzzo F; Nair G; Sethi V; Kolb H; Ohayon J; Wu T; Cortese ICM; Reich DS
JAMA Neurol; 2019 Dec; 76(12):1474-1483. PubMed ID: 31403674
[TBL] [Abstract][Full Text] [Related]
6. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
[TBL] [Abstract][Full Text] [Related]
7. How patients with multiple sclerosis acquire disability.
Lublin FD; Häring DA; Ganjgahi H; Ocampo A; Hatami F; Čuklina J; Aarden P; Dahlke F; Arnold DL; Wiendl H; Chitnis T; Nichols TE; Kieseier BC; Bermel RA
Brain; 2022 Sep; 145(9):3147-3161. PubMed ID: 35104840
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
Kappos L; Wolinsky JS; Giovannoni G; Arnold DL; Wang Q; Bernasconi C; Model F; Koendgen H; Manfrini M; Belachew S; Hauser SL
JAMA Neurol; 2020 Sep; 77(9):1132-1140. PubMed ID: 32511687
[TBL] [Abstract][Full Text] [Related]
9. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
[TBL] [Abstract][Full Text] [Related]
10. Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years.
Reeves JA; Mohebbi M; Wicks T; Salman F; Bartnik A; Jakimovski D; Bergsland N; Schweser F; Weinstock-Guttman B; Dwyer MG; Zivadinov R
Mult Scler; 2024 Apr; 30(4-5):535-545. PubMed ID: 38366920
[TBL] [Abstract][Full Text] [Related]
11. Contribution of relapse-associated worsening to overall disability accrual in patients with relapsing-onset multiple sclerosis: A mediation analysis.
Chen B; Ji SQ; Shen F; Tian DS; Bu BT
Mult Scler Relat Disord; 2022 Mar; 59():103555. PubMed ID: 35093839
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
[TBL] [Abstract][Full Text] [Related]
13. Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.
Müller J; Cagol A; Lorscheider J; Tsagkas C; Benkert P; Yaldizli Ö; Kuhle J; Derfuss T; Sormani MP; Thompson A; Granziera C; Kappos L
JAMA Neurol; 2023 Nov; 80(11):1232-1245. PubMed ID: 37782515
[TBL] [Abstract][Full Text] [Related]
14. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
[TBL] [Abstract][Full Text] [Related]
15. Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique.
Tur C; Grussu F; De Angelis F; Prados F; Kanber B; Calvi A; Eshaghi A; Charalambous T; Cortese R; Chard DT; Chataway J; Thompson AJ; Ciccarelli O; Gandini Wheeler-Kingshott CAM
Neuroimage Clin; 2022; 33():102904. PubMed ID: 34875458
[TBL] [Abstract][Full Text] [Related]
16. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
Xiang B; Wen J; Cross AH; Yablonskiy DA
J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
[TBL] [Abstract][Full Text] [Related]
17. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
[TBL] [Abstract][Full Text] [Related]
18. An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression.
Ananthavarathan P; Sahi N; Chard DT
Expert Rev Neurother; 2024 Feb; 24(2):201-216. PubMed ID: 38235594
[TBL] [Abstract][Full Text] [Related]
19. Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis.
Lim TRU; Kumaran SP; Suthiphosuwan S; Espiritu AI; Jones A; Lin AW; Oh J; Bharatha A
Mult Scler; 2024 Apr; 30(4-5):505-515. PubMed ID: 38419027
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
